Ph1 FIH study of JZP815 in participants with solid tumors harboring MAPK pathway
Phase I Clinical Trial
Phase 1 FIH open-label nonrandomized multicenter study of JZP815 in participants with advanced or metastatic solid tumors harboring alterations in the MAPK pathway (JZ815-101)